{"id":34807,"date":"2026-09-30T10:35:42","date_gmt":"2026-09-30T14:35:42","guid":{"rendered":"https:\/\/therapytoronto.ca\/news\/?p=34807"},"modified":"2026-09-30T09:40:25","modified_gmt":"2026-09-30T13:40:25","slug":"researchers-find-benzodiazepine-prescriptions-drop-sharply-in-the-u-s-over-the-past-decade","status":"publish","type":"post","link":"https:\/\/therapytoronto.ca\/news\/2026\/09\/researchers-find-benzodiazepine-prescriptions-drop-sharply-in-the-u-s-over-the-past-decade\/","title":{"rendered":"Researchers find benzodiazepine prescriptions drop sharply in the U.S. over the past decade"},"content":{"rendered":"<p>The number of benzodiazepine prescriptions like Xanax and Valium dispensed in the United States decreased over the past 10 years, potentially suggesting that doctors have become more cautious when prescribing these <strong>sedatives<\/strong>, according to Rutgers Health researchers.<\/p>\n<p>The medications, which also include Ativan and Klonopin, slow down the activity of the central nervous system and are commonly used to treat anxiety, panic attacks, insomnia and some seizure disorders.<\/p>\n<p>In the <a href=\"https:\/\/doi.org\/10.1176\/appi.ajp.20251346\">study<\/a>, published in the <em>American Journal of Psychiatry<\/em>, Rutgers Health researchers analyzed more than 1.1 billion benzodiazepine prescription fills between 2013 and 2024 and found a 26.7%\u00a0decline\u00a0during this period.<\/p>\n<p>\u201cBenzodiazepines are among the most commonly prescribed medications in the United States, and they provide meaningful benefits for many patients,\u201d said <a href=\"https:\/\/ifh.rutgers.edu\/profile\/naomi-cruz\/\">Naomi Cruz<\/a>, a recent doctoral graduate at the <a href=\"https:\/\/sph.rutgers.edu\/\">Rutgers School of Public Health<\/a> and <a href=\"https:\/\/ifh.rutgers.edu\/research\/centers-and-programs\/research-centers\/the-center-for-pharmacoepidemiology-and-treatment-sciences\/\">Rutgers Center for Pharmacoepidemiology and Treatment Science<\/a> \u00a0and the lead author of the study. \u201cBut these medications also carry risks, particularly when used with other drugs or over long periods of time. Our findings suggest that prescribing practices may have become more cautious or selective over the past decade, but continued monitoring is important to ensure that patients receive the safest care.\u201d<\/p>\n<p>Benzodiazepine medications are <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35415793\/\">increasingly involved in overdose deaths<\/a>, many of which are in combination with other drugs such as opioids. The Food and Drug Administration issued warnings about <a href=\"https:\/\/www.fda.gov\/drugs\/food-and-drug-administration-overdose-prevention-framework\/new-safety-measures-announced-opioid-analgesics-prescription-opioid-cough-products-and\">prescribing these medications along with opioids<\/a> and <a href=\"https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class\">risks of medication misuse<\/a> in 2016 and 2020. The prevalence of prescriptions decreased across all patient populations, with the largest decline observed among young adults between ages 18 and 29.<\/p>\n<p>Amidst a changing health care workforce, researchers also found shifts in who was prescribing the medications. <strong>Primary care physicians and psychiatrists<\/strong> wrote fewer prescriptions while prescriptions by advanced practice providers \u2013 such as nurse practitioners and physician assistants \u2013 increased.<\/p>\n<p>Researchers also found declines in the <strong>amount of medication<\/strong> dispensed per prescription. The average dose per prescription decreased by 18.3%, which may reflect the adoption of more selective prescribing practices, the researchers said.<\/p>\n<p>\u201cWhile the trends we observed may indicate shifts toward safer prescribing, ongoing research can help us better understand how practices are evolving and where opportunities exist to improve care,\u201d said Cruz.<\/p>\n<p>Coauthors of the study include Hillary Samples, Greta Bushnell, Stephen Crystal and Fangzhou Xie of Rutgers Institute for Health, Health Care Policy and Aging Research and Mark Olfson of Columbia University.<\/p>\n<p>This research was supported in part by the National Institute on Drug Abuse, K01DA050769. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.<\/p>\n<hr class=\"hidden-xs hidden-sm\" \/>\n<div class=\"featured_image\">\n<div class=\"details\">\n<div class=\"well\">\n<h4>JOURNAL<\/h4>\n<p>American Journal of Psychiatry<\/p>\n<\/div>\n<div class=\"well\"><\/div>\n<\/div>\n<\/div>\n<!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>The number of benzodiazepine prescriptions like Xanax and Valium dispensed in the United States decreased over the past 10 years, potentially suggesting that doctors have become more cautious when prescribing these sedatives, according to Rutgers Health researchers. The medications, which also include Ativan and Klonopin, slow down the activity of the central nervous system and&hellip;&nbsp;<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":3,"featured_media":20661,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"no","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[350,361,1050,976,938],"tags":[1065,1131,1133,1132],"class_list":["post-34807","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-addictions","category-disorders","category-drugs","category-medical","category-medication-3","tag-benzodiazepine","tag-sedatives","tag-valium","tag-xanax"],"_links":{"self":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/34807","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/comments?post=34807"}],"version-history":[{"count":1,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/34807\/revisions"}],"predecessor-version":[{"id":34808,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/34807\/revisions\/34808"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/media\/20661"}],"wp:attachment":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/media?parent=34807"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/categories?post=34807"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/tags?post=34807"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}